Eddie Lo
Foot Surgery · Tacoma, WANPI 1902847551
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (52.6%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Smith+Nephew accounts for 69.2% of it on its own, with 21 other manufacturers making up the rest. Reporting peaked in 2019 at $10,027 and has fallen 90.6% since, to $943 in 2025.
Across 155 payments — averaging $85.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$9K
- Arthrosurface Incorporated$2K
- Medtronic$572
- Treace Medical Concepts, Inc.$412
- Mimedx Group, Inc.$405
- Osiris Therapeutics Inc.$360
- plus $807 from 16 others
What the payments were for
- Speaking & faculty fees$7,00053%
- Travel & lodging$1,46311%
- Food & beverage$4,85736%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 56 | $9,219 |
| Arthrosurface Incorporated | 11 | $1,544 |
| Medtronic | 38 | $572 |
| Treace Medical Concepts, Inc. | 12 | $412 |
| Mimedx Group, Inc. | 7 | $405 |
| Osiris Therapeutics Inc. | 5 | $360 |
| Stryker(2 entities) | 3 | $276 |
| Johnson & Johnson | 2 | $96 |
| ANI Pharmaceuticals, Inc. | 3 | $85 |
| Orthofix Medical, Inc. | 3 | $63 |
| Paratek Pharmaceuticals, Inc. | 3 | $58 |
| DJO, LLC | 1 | $49 |
| Bioventus LLC | 2 | $28 |
| Fusion Orthopedics USA, LLC | 1 | $25 |
| Convatec Inc. | 1 | $20 |
| Paragon 28, Inc. | 1 | $18 |
| Nevro Corp. | 1 | $17 |
| Next Science LLC | 1 | $16 |
| Biowound Solutions, Inc. | 1 | $16 |
| Krystal Biotech Inc | 1 | $15 |
| AbbVie | 1 | $11 |
| Amniox Medical, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Stravix$7,065
- HemiCAP MTP Resurfacing$1,299
- Grafix PL PRIME$624
- Grafix PRIME$500
- Grafix CORE$500
- Grafix XC$500
- GRAFIX PL$287
- Lapiplasty System$144
- SIMPLICITI$131
- INTELLIS ADAPTIVESTIM$123
- PERFORM GLENOID$123
- ACTICOAT 4" X 4"$116
- ALLEVYN HEEL 10.5CM X 13.5CM CTN 5$116
- Iodosorb Ointment 40g USA$116
- COLLAGENASE SANTYL$116
- Grafix$101
- GrafixPL$101
How this compares
Too few foot surgery providers in Washingtonto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 28 | $223 |
Paid to pharmacies, not to this prescriber.
Other foot surgery in Tacoma
- Natalie ChuTacoma$4K
- Chad FarleyLakewood$4K
- Abdulaziz KimawiFederal Way$4K
- David GriffinVancouver$2K
- Lyle LorimerSeattle$759
- Ronald DouglasSpokane$745
- Shawn SummersYakima$538
- Samuel LiebsonPort Angeles$319
- Chad SmithPuyallup$261
- Michael SherwinBellingham$151
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.